M. Xing, Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications, Endocrine Reviews, vol.28, issue.7, pp.742-62, 2007.
DOI : 10.1210/er.2007-0007

P. Lito, C. Pratilas, E. Joseph, M. Tadi, E. Halilovic et al., Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas. Cancer cell, pp.668-82, 2012.

C. Mitsiades, J. Negri, C. Mcmullan, D. Mcmillin, E. Sozopoulos et al., Targeting BRAFV600E in thyroid carcinoma: therapeutic implications, Molecular Cancer Therapeutics, vol.6, issue.3, pp.1070-1078, 2007.
DOI : 10.1158/1535-7163.MCT-06-0449

H. Zuo, Y. Nakamura, H. Yasuoka, P. Zhang, M. Nakamura et al., Lack of association between BRAF V600E mutation and mitogen-activated protein kinase activation in papillary thyroid carcinoma, Pathology International, vol.99, issue.1
DOI : 10.1093/emboj/19.12.2900

T. Yeh, V. Marsh, B. Bernat, J. Ballard, H. Colwell et al., Biological characterization of ARRY- 142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor. Clinical cancer research: an official journal of the American Association for Cancer Research, pp.1576-83, 2007.

J. Lee, S. Huang, M. Lee, S. Lee, M. Ryu et al., Dual specificity phosphatase 6 as a predictor of invasiveness in papillary thyroid cancer, European Journal of Endocrinology, vol.167, issue.1, pp.93-101, 2012.
DOI : 10.1530/EJE-12-0010

J. Mackeigan, L. Murphy, and J. Blenis, Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance, Nature Cell Biology, vol.89, issue.6, pp.591-600, 2005.
DOI : 10.1016/j.ccr.2005.01.010

L. Rushworth, A. Kidger, L. Delavaine, G. Stewart, S. Van-schelven et al., )-driven SerpinB2 expression, Proceedings of the National Academy of Sciences, vol.312, issue.3, pp.18267-72, 2014.
DOI : 10.1016/j.cell.2014.01.040

L. Dultz, S. Dhar, J. Ogilvie, K. Heller, D. Bar-sagi et al., Clinical and therapeutic implications of Sprouty2 feedback dysregulation in BRAF V600E-mutation-positive papillary thyroid cancer, Surgery, vol.154, issue.6, pp.1239-1283, 2013.
DOI : 10.1016/j.surg.2013.06.024

C. Pratilas, B. Taylor, Q. Ye, A. Viale, C. Sander et al., V600EBRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway, Proceedings of the National Academy of Sciences, vol.17, issue.1, pp.4519-4543, 2009.
DOI : 10.1091/mbc.E05-09-0824

C. Montero-conde, S. Ruiz-llorente, J. Dominguez, J. Knauf, A. Viale et al., -Mutant Thyroid Carcinomas, Cancer Discovery, vol.3, issue.5, pp.520-553, 2013.
DOI : 10.1158/2159-8290.CD-12-0531
URL : https://hal.archives-ouvertes.fr/in2p3-00564521

S. Bellou, M. Hink, E. Bagli, E. Panopoulou, P. Bastiaens et al., VEGF autoregulates its proliferative and migratory ERK1/2 and p38 cascades by enhancing the expression of DUSP1 and DUSP5 phosphatases in endothelial cells, AJP: Cell Physiology, vol.297, issue.6, pp.1477-89, 2009.
DOI : 10.1152/ajpcell.00058.2009

C. Buffet, M. Catelli, K. Hecale-perlemoine, L. Bricaire, C. Garcia et al., Dual Specificity Phosphatase 5, a Specific Negative Regulator of ERK Signaling, Is Induced by Serum Response Factor and Elk-1 Transcription Factor, PLOS ONE, vol.8, issue.3, p.145484, 2015.
DOI : 10.1371/journal.pone.0145484.g011

M. Ekerot, M. Stavridis, L. Delavaine, M. Mitchell, C. Staples et al., gene promoter, Biochemical Journal, vol.412, issue.2, pp.287-98, 2008.
DOI : 10.1042/BJ20071512
URL : https://hal.archives-ouvertes.fr/hal-00478912

Z. Zhang, S. Kobayashi, A. Borczuk, R. Leidner, T. Laframboise et al., Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells, Carcinogenesis, vol.31, issue.4, pp.577-86, 2010.
DOI : 10.1093/carcin/bgq020

N. Bluthgen, S. Legewie, S. Kielbasa, A. Schramme, O. Tchernitsa et al., A systems biological approach suggests that transcriptional feedback regulation by dual-specificity phosphatase???6 shapes extracellular signal-related kinase activity in RAS-transformed fibroblasts, FEBS Journal, vol.29, issue.4, pp.1024-1059, 2009.
DOI : 10.1093/nar/29.9.e45

E. Hodis, I. Watson, G. Kryukov, S. Arold, M. Imielinski et al., A Landscape of Driver Mutations in Melanoma, Cell, vol.150, issue.2, pp.251-63, 2012.
DOI : 10.1016/j.cell.2012.06.024

S. Shin, S. Park, and G. Kang, Down-Regulation of Dual-Specificity Phosphatase 5 in Gastric Cancer by Promoter CpG Island Hypermethylation and Its Potential Role in Carcinogenesis, The American Journal of Pathology, vol.182, issue.4, pp.1275-85, 2013.
DOI : 10.1016/j.ajpath.2013.01.004

C. Caunt and S. Keyse, Dual-specificity MAP kinase phosphatases (MKPs), FEBS Journal, vol.1784, issue.2, pp.489-504, 2013.
DOI : 10.1016/j.bbapap.2007.09.016

C. Caunt, S. Armstrong, C. Rivers, M. Norman, and C. Mcardle, Spatiotemporal Regulation of ERK2 by Dual Specificity Phosphatases, Journal of Biological Chemistry, vol.114, issue.39, pp.26612-26635, 2008.
DOI : 10.1074/jbc.M303264200